Generic multi-step therapeutic treatment protocol
A generic treatment protocol is disclosed for therapeutically treating a patient via an implantable treatment device. Treatment steps can be defined to start and end at absolute times, or can be programmed via telemetry to start a certain amount of time after termination of a previously executed treatment step. Treatment steps have a treatment rate or dose attribute and a duration attribute. Treatment steps may optionally enable patient-activated bolus overlays. Patient-activated rate or dosage adjustments can also optionally be enabled. Repeated-execution treatment-step groups are also provided. Such treatment-step groups can have start and end times, a group duration, and a group total dose, each defined in a manner similar to that for a treatment step. Treatment-step groups include a repetition count, which could be set to a value that causes the group to repeat forever. Single execution treatment steps can, accordingly, be programmed to execute before and/or after a repeated-execution treatment-step group.
1. A computer-readable medium containing computer-executable instructions that cause a human-implantable therapeutic treatment device to perform a specific therapeutic treatment protocol by performing steps comprising:
performing at least one treatment step that is defined, at least in part, by generic treatment parameters including a treatment rate or dose and a treatment duration, which have been downlinked to the treatment device;
performing at least one treatment-step group a number of times that is specified by a treatment-step-group repetition count that has been downlinked to the treatment device; and
administering at least one activated bolus in accordance with downlinked generic treatment parameters including:
a start delay or start time,
a treatment rate or dose, and
a treatment duration.
2. The computer-readable medium of claim 1 , wherein the at least one treatment step starts executing after a programmed delay relative to when the generic treatment protocol parameters are downlinked to the implantable device.
3. The computer-readable medium of claim 1 , wherein the at least one treatment step is programmed to start executing after a predetermined amount of time elapses following completion of a preceding treatment step.
4. The computer-readable medium of claim 1 , wherein the at least one treatment step starts executing at a programmed absolute start time.
5. The computer-readable medium of claim 1 , comprising further computer-executable instructions for performing a patient-activated bolus while performing the at least one treatment step.
6. The computer-readable medium of claim 5 , comprising further computer-executable instructions for disallowing an attempted patient-activated rate adjustment that would exceed a programmed maximum rate adjustment for the at least one treatment step.
7. The computer-readable medium of claim 1 , wherein the at least one treatment-step group starts and ends in accordance with an absolute start time and an absolute end time, respectively.
8. The computer-readable medium of claim 1 , wherein the at least one treatment-step group starts in accordance with a programmed delay relative to completion of an earlier executed treatment step.
9. The computer-readable medium of claim 1 , wherein the at least one treatment step group includes providing treatment at a background rate when no treatment step is actively providing treatment.
10. The computer-readable medium of claim 1 , wherein a maximum amount of treatment administered by the at least one treatment-step group is limited by a programmed maximum dosage.
11. The computer-readable medium of claim 1 , wherein the treatment-step-group repetition count specifies that the at least one treatment-step group should repeat forever.
12. The computer-readable medium of claim 1 , wherein the bolus includes a programmed priority that specifies that the bolus has a priority selected from the group consisting of:
a low-priority patient-activated bolus that takes precedence over treatment steps that specifically allow themselves to be overlaid by low-priority boluses, and
a high-priority physician-activated bolus that takes precedence over treatment steps.
13. A system for causing a human-implantable therapeutic treatment device to perform a specific therapeutic treatment protocol, the system comprising:
means for performing at least one treatment step that is defined, at least in part, by generic treatment parameters including a treatment rate or dose and a treatment duration, which have been downlinked to the treatment device;
means for performing at least one treatment-step group a number of times that is specified by a treatment-step-group repetition count that has been downlinked to the treatment device; and
means for administering at least one activated bolus in accordance with downlinked generic treatment parameters including:
a start delay or start time,
a treatment rate or dose, and
a treatment duration.
14. The system of claim 13 , wherein the at least one treatment step starts executing after a programmed delay relative to when the generic treatment protocol parameters are downlinked to the implantable device.
15. The system of claim 13 , wherein the at least one treatment step is programmed to start executing after a predetermined amount of time elapses following completion of a preceding treatment step.
16. The system of claim 13 , wherein the at least one treatment step starts executing at a programmed absolute start time.
17. The system of claim 13 , further comprising: means for performing a patient-activated bolus while performing the at least one treatment step.
18. The system of claim 13 , further comprising: disallowing an attempted patient-activated rate adjustment that would exceed a programmed maximum rate adjustment for the at least one treatment step.
19. The system of claim 13 , wherein the at least one treatment-step group starts and ends in accordance with an absolute start time and an absolute end time, respectively.
20. The system of claim 13 , wherein the at least one treatment-step group starts in accordance with a programmed delay relative to completion of an earlier executed treatment step.
21. The system of claim 13 , wherein the at least one treatment step group includes means for providing treatment at a background treatment while no treatment step is actively providing treatment.
22. The system of claim 13 , wherein a maximum amount of treatment administered by the at least one treatment-step group is limited by a programmed maximum dosage.
23. The system of claim 13 , wherein the treatment-step-group repetition count specifies that the at least one treatment-step group should repeat forever.
24. The system of claim 13 , wherein the bolus includes a programmed priority that specifies that the bolus has a priority selected from the group consisting of:
a low-priority patient-activated bolus that takes precedence over treatment steps that specifically allow themselves to be overlaid by low-priority boluses, and
a high-priority physician-activated bolus that takes precedence over treatment steps.